Mizuho Securities Starts Centene (CNC) at Neutral

Mizuho Securities analyst Ann Hynes initiates coverage on Centene (NYSE: CNC) with a Neutral rating and a price target of $65.00.

The analyst comments "We are initiating coverage of CNC with a Neutral Rating and $65 price target. CNC is the bellwether Medicaid provider, boasting a national market share of ~19%. As a result, the company is positively leveraged to the current Washington backdrop. A major concern for us is the company’s M&A strategy, given the high dependence on forecasted growth from acquisitions. In a market where assets are becoming more scare, more competitive, and more expensive, we worry about financial discipline in order to achieve its long-term revenue goals."

For an analyst ratings summary and ratings history on Centene click here. For more ratings news on Centene click here.

Shares of Centene closed at $61.72 yesterday.

You May Also Be Interested In

• UPDATE: H.C. Wainwright Starts Addex Therapeutics (ADXN) at Buy
• China Life Insurance Co. Ltd. (2628:HK) (LFC) PT Lowered to HK$23 at Goldman Sachs
• Brunswick Corp (BC) PT Raised to $120 at Jefferies as High HP Competitive Advantage Boosted by Reopening